{"id":1182628,"date":"2026-11-12T13:24:09","date_gmt":"2026-11-12T13:24:09","guid":{"rendered":"https:\/\/www.europesays.com\/us\/1182628\/"},"modified":"2026-11-12T13:24:09","modified_gmt":"2026-11-12T13:24:09","slug":"deloitte-cuts-glp-1-weight-loss-coverage-as-healthcare-costs-rise","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/1182628\/","title":{"rendered":"Deloitte Cuts GLP-1 Weight Loss Coverage As Healthcare Costs Rise"},"content":{"rendered":"<p>Deloitte&#8217;s US employees are joining the growing list of workers facing more expensive and less generous healthcare benefits.<\/p>\n<p>According to an internal benefits guide seen by Business Insider, from January, the <a target=\"_self\" class=\"\" href=\"https:\/\/www.businessinsider.com\/deloitte-gives-us-employees-new-job-titles-leader-role-2026-1\" data-track-click=\"{&quot;element_name&quot;:&quot;body_link&quot;,&quot;event&quot;:&quot;tout_click&quot;,&quot;index&quot;:&quot;bi_value_unassigned&quot;,&quot;product_field&quot;:&quot;bi_value_unassigned&quot;}\" rel=\"nofollow noopener\">Big Four firm<\/a> will no longer cover GLP-1 medication for weight-loss purposes through its medical plans.<\/p>\n<p>At the same time, Deloitte employees will also face higher deductibles and out-of-pocket maximums under most health plans, the document said, meaning higher costs both before and after coverage kicks in.<\/p>\n<p>The changes come as corporate America battles a widespread rise in health insurance costs for both employees and employers.<\/p>\n<p>Deloitte told staff in the document that the changes &#8220;reflect the hard trade-offs of today&#8217;s cost environment,&#8221; and that there was a need &#8220;for shared responsibility in a few specific places where it&#8217;s become untenable for Deloitte to carry the cost alone.&#8221;<\/p>\n<p>GLP-1 medication will remain covered when prescribed for diabetes and other covered medical conditions, the document said. For those seeking support with weight loss, Deloitte is instead offering employees access to a virtual lifestyle program called eMed that includes coaching and a $125-per-prescription<strong> <\/strong>employer contribution.<\/p>\n<p>List prices for common GLP-1s like semaglutide and tirzepatide are generally in excess of $1,000, though direct purchase programs such as LillyDirect and government plans like TrumpRx mean the costs are often significantly lower.<\/p>\n<p>TrumpRx, for instance, offers semaglutide injection pens under the Ozempic brand name for between $199 and $499.<\/p>\n<p>A Deloitte spokesperson told Business Insider that, like other large employers, the firm has made select modifications where cost growth rates are no longer sustainable. The new support for weight-related uses of GLP-1s includes direct-from-manufacturer drug pricing, they said.<\/p>\n<p>                                Want more Business Insider in your news feed?<\/p>\n<p class=\"preferred-sources-module-desc body-xs\">\n                                  Add BI in Google so our reporting is easier to find when you\u2019re searching for what matters.\n                                <\/p>\n<p>&#8220;Our financial commitment to our people and their families continues to grow,&#8221; the spokesperson said.<\/p>\n<p>Have a tip to share? Contact this reporter via email at <a target=\"_blank\" href=\"https:\/\/www.businessinsider.com\/mailto:pthompson@businessinsider.com\" data-track-click=\"{&quot;click_type&quot;:&quot;other&quot;,&quot;element_name&quot;:&quot;callout_box&quot;,&quot;event&quot;:&quot;outbound_click&quot;}\" rel=\" nofollow noopener\">pthompson@businessinsider.com<\/a> or Signal at Polly_Thompson.89. Use a personal email address, a nonwork WiFi network, and a nonwork device; here&#8217;s our guide to <a target=\"_self\" rel=\"nofollow noopener\" href=\"https:\/\/www.businessinsider.com\/insider-guide-to-securely-sharing-whistleblower-information-about-powerful-institutions-2021-10\" data-track-click=\"{&quot;element_name&quot;:&quot;callout_box&quot;,&quot;event&quot;:&quot;tout_click&quot;,&quot;index&quot;:&quot;bi_value_unassigned&quot;,&quot;product_field&quot;:&quot;bi_value_unassigned&quot;}\">sharing information securely<\/a>.<\/p>\n<p>Deloitte is also expanding certain healthcare coverage, including improving long-term disability protection and adding free annual eye exams to its company-paid discount vision program.<\/p>\n<p>The benefits guide seen by Business Insider applies to what Deloitte calls its &#8220;Core, Domain, and Enterprise professionals,&#8221; which includes the majority of its traditional client-facing accountants, consultants, and technical specialists. The firm employs about 181,000 people in the US.<\/p>\n<p>Health insurance costs are rising across the board<\/p>\n<p>                  <img xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"lazy-image \" encoding=\"UTF-8\" width=\"1\" height=\"1\" data-content-type=\"image\/jpeg\" srcs=\"{&quot;https:\/\/i.insider.com\/6733994f5ec9bfa3d63d91aa&quot;:{&quot;contentType&quot;:&quot;image\/jpeg&quot;,&quot;aspectRatioW&quot;:4667,&quot;aspectRatioH&quot;:3111}}\" alt=\"A close-up image of currently available injectable medications Wegovy and Ozempic along with pills for weight loss.\"\/><\/p>\n<p>                          Deloitte is one of many employers cutting GLP-1 coverage for weight loss purposes.\u00a0<\/p>\n<p>                  Michael Siluk\/UCG\/Universal Images Group via Getty Images<\/p>\n<p>Deloitte&#8217;s changes to its coverage mirror a broader squeeze on <a target=\"_self\" class=\"\" href=\"https:\/\/www.businessinsider.com\/what-to-do-healthcare-costs-are-eating-into-your-raises-2026-8\" data-track-click=\"{&quot;element_name&quot;:&quot;body_link&quot;,&quot;event&quot;:&quot;tout_click&quot;,&quot;index&quot;:&quot;bi_value_unassigned&quot;,&quot;product_field&quot;:&quot;bi_value_unassigned&quot;}\" rel=\"nofollow noopener\">US employer health plans.<\/a> As healthcare costs and demand climb, everyone is paying more.<\/p>\n<p>A 2026 health benefits survey from KFF found that workers on a family plan paid an average of $7,471 a year in premiums \u2014 a 9% increase from 2025. When accounting for employer contributions, family plan premiums totaled $28,303 in 2026, a roughly 5% increase from 2025.<\/p>\n<p>                      More of Business Insider&#8217;s healthcare coverage<\/p>\n<p><a target=\"_self\" class=\"\" href=\"https:\/\/www.businessinsider.com\/lost-100-pounds-zepbound-insurance-denials-ozempic-cancer-2026-4\" data-track-click=\"{&quot;element_name&quot;:&quot;body_link&quot;,&quot;event&quot;:&quot;tout_click&quot;,&quot;index&quot;:&quot;bi_value_unassigned&quot;,&quot;product_field&quot;:&quot;bi_value_unassigned&quot;}\" rel=\"nofollow noopener\">Restricting eligibility for GLP-1s<\/a> has become a common route for employers looking to curb healthcare spending.<\/p>\n<p>The drugs were developed to treat diabetes, but have become sought-after treatments for obesity and related chronic conditions. Aon, an insurance broker and employee-benefits consultancy, found that use of GLP-1s was up 75% in 2025.<\/p>\n<p>The drugs&#8217; rapid uptake and potential for long-term use have made them a costly pressure point for insurers and employer health plans. Aon found that 39% of employers planned to reduce or restrict GLP-1 coverage in 2026.<\/p>\n<p>PwC and <a target=\"_self\" href=\"https:\/\/www.businessinsider.com\/starbucks-cuts-glp-1-coverage-weight-loss-costs-climb-2026-8\" data-track-click=\"{&quot;element_name&quot;:&quot;body_link&quot;,&quot;event&quot;:&quot;tout_click&quot;,&quot;index&quot;:&quot;bi_value_unassigned&quot;,&quot;product_field&quot;:&quot;bi_value_unassigned&quot;}\" rel=\"nofollow noopener\">Starbucks<\/a> are among those that have pulled back their coverage for weight-loss purposes this year.<\/p>\n<p>Deloitte has also introduced <a target=\"_self\" class=\"\" href=\"https:\/\/www.businessinsider.com\/deloitte-cuts-down-benefits-for-some-workers-big-four-ai-2026-4?utm_source=linkedin&amp;utm_medium=social&amp;utm_campaign=business-headline-graphic\" data-track-click=\"{&quot;element_name&quot;:&quot;body_link&quot;,&quot;event&quot;:&quot;tout_click&quot;,&quot;index&quot;:&quot;bi_value_unassigned&quot;,&quot;product_field&quot;:&quot;bi_value_unassigned&quot;}\" rel=\"nofollow noopener\">broader benefit changes<\/a> for a select group of staff. In April, Business Insider reported that for staff in Deloitte&#8217;s Center talent model \u2014 which mostly includes internal-facing admin roles \u2014 parental leave, annual PTO, and IVF funding would be reduced or eliminated as of January 1, 2027.<\/p>\n<p>Deloitte&#8217;s Americas division was its slowest-growing region globally in the financial year ending May 31, 2026, with revenue rising 3.2%, down from 7.1% growth a year earlier.<\/p>\n","protected":false},"excerpt":{"rendered":"Deloitte&#8217;s US employees are joining the growing list of workers facing more expensive and less generous healthcare benefits.&hellip;\n","protected":false},"author":3,"featured_media":1182629,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[35],"tags":[4381,6997,470613,470614,21591,35328,17286,6982,210,1141,227188,1142,6831,67,132,68,406659,470615,470616,20175,1628],"class_list":["post-1182628","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-business-insider","tag-change","tag-common-glp-1s","tag-cost-environment","tag-coverage","tag-deloitte","tag-document","tag-employer","tag-health","tag-health-care","tag-health-insurance-cost","tag-healthcare","tag-staff","tag-united-states","tag-unitedstates","tag-us","tag-us-employee","tag-us-employer-health-plan","tag-us-staff","tag-use","tag-year"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/117603694215062853","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1182628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=1182628"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1182628\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/1182629"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=1182628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=1182628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=1182628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}